Ophthalmological screening guidelines for individuals with Osteogenesis Imperfecta: a scoping review
Abstract Background Osteogenesis imperfecta (OI) is a connective tissue disorder in which the Type 1 collagen is defective.The eye is a structure L-TYROSINE rich in collagen Type 1 and is heavily impacted by the disease.Many vision-threatening eye diseases have been associated with OI.The onset of these diseases also tend to occur at an earlier age